A variety of topical antiseptic substances have been used historically to treat open wounds with suspected tissue infection or that are slow to heal. However, the effectiveness of these substances in treating infected or recalcitrant wounds remains controversial.
Recent Advances:
Newly formulated topical antiseptics delivered through differing dressing technologies, such as ionic substances, hold the potential to limit the development of and treat antibiotic-resistant microbes in open wounds. Other topically delivered substances, such as insect-derived substances, orthomolecular agents, and phytochemicals, also present opportunities to optimize wound healing by decreasing tissue bioburden and facilitating the wound healing process.
Critical Issues:
Limited systemic perfusion of open wounds in individuals with certain diagnoses, such as peripheral arterial disease or necrotizing infection and the increasing number of antibiotic-resistant wound pathogens, suggests a continued role for topically applied antiseptic agents. Likewise, the failure of wounds to heal when treated with standard of care therapy opens the door to innovative treatment approaches that include the natural substances described in this article.
Future Directions:
Evidence for the use of select topical antiseptic agents from each of the aforementioned categories will be discussed in this article. Additional well-controlled clinical studies are needed to provide definitive recommendations for many of these topical agents.
CooperR. A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds. Published 2004; www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobial-Agents.html. Retrieved December1, 2012.
WhiteRJ, CooperR, KingsleyA. Wound colonization and infection: the role of topical antimicrobials. Br J Nurs, 2001; 10:563–578.
5.
WhiteRJ, CuttingK, KingsleyA. Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manag, 2006; 52:26–58.
6.
O'MearaS, et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev, 2014:CD003557.
7.
FlemingA. The action of chemical and physiological antiseptics in a septic wound. Br J Surg, 1919; 7:99–129.
8.
ZamoraJL, PriceMF, ChuangP, GentryLO. Inhibition of povidone-iodine's bactericidal ability by common organic substances; an experimental study. Surgery, 1985; 98:25–29.
9.
KucanJO, RobsonMC, HeggersJP, KoF. Comparison of silver sulfadiazine, povidone-iodine and physiological saline in the treatment of chronic pressure ulcers. J Am Geriatr Soc, 1981; 29:232–235.
10.
TatnallFM, LeighIM, GibsonJR. Comparative study of antiseptic toxicity on basal keratinocytes, transformed keratinocytes and fibroblasts. Skin Pharmacol, 1990; 3:157–163.
BrennanSS, LeaperDJ. The effect of antiseptics on the healing wound: A study using the rabbit ear chamber. Br J Surg, 1985; 72:780–782.
13.
MullikenJB, HealeyNA, GlowackiJ. Povidone iodine and tensile strength of wounds in rats. J Trauma, 1980; 20:323–324.
14.
BennettL, RichardS, DavidsonC, JefferyM, BartonR, NanneyL. An in vivo comparison of topical agents on wound repair. J Plast Reconstr Surg, 2001; 108:675.
15.
SelvaggiG, MonstryS, Van LanduytK, HamdiM, BlondeelPH. The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg, 2003; 103:241–247.
16.
SibbaldRG, GoodmanL, WooKY, et al. In: KrasnerD, RodeheaverG, SibbaldD, WooK, eds. Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, 5th edition. Malvern, PA: HMP Communications, 2012:173–197.
17.
ZhouLH, et al. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol, 2002; 146:365.
18.
O'MearaS, Al-Kurdi DOL, ogunY, et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev, 2010:CD003557.
19.
MobergS, HoffmanL, GrennertML, HolstA. A randomized trial of cadexomer iodine in decubitus ulcers. J Am Geriatr, 1983; 31:462–465.
20.
StottsN. Wound Infection: Diagnosis and Management. In: BryantR, NixD, eds. Acute & Chronic Wounds: Current Management Concepts, 3rd edition. St. Louis, MO: Mosby/Elsevier, 2007:161–173.
21.
GreerN, FomanN, DorrianJ, et al. Advanced Wound Care Therapies for Non-Healing Diabetic, Venous, and Arterial Ulcers: A Systematic Review. VA-ESP Project #09-009; Published Nov: 2012 at www.hsrd.research.va.gov/publications/esp/wound-care.pdf.
22.
RussellAD, HugoWB. Antimicrobial activity and action of silver. Prog Med Chem, 1994; 31:351–370.
23.
BelcaroG, CesaroneMR, ErrichiBM, et al. Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. Panminerva Med, 2010; 52(2 Suppl 1):37–42.
24.
JorgensenB, PriceP, AndersenKE, et al. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J, 2005; 2:64–73.
25.
MillerCN, NewallN, KappSE, et al. A randomized-controlled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers. Wound Rep Reg, 2010; 18:359–367.
26.
JudeEB, ApelqvistJ, SpraulM, MartiniJ; Silver Dressing Study Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med, 2007; 24:280–288.
27.
VermeulenH, van HattemJM, Storm-VerslootMN, UbbinkDT, WesterbosSJ. Topical silver for treating infected wounds. Cochrane Database Syst Rev, 2007:CD005486.
28.
LoSF, ChangCJ, HuWY, et al. The effectiveness of silver-releasing dressings in the management of nonhealing chronic wounds: a meta-analysis. J Clin Nurs, 2009; 18:716–728.
29.
LaforetK, BaronRA, WoodburyMG, SibbaldRG. Alternative and complimentary therapies for wound care. In: KrasnerRodeheaver, SibbaldWoo, eds. Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, 5th edition. Malvern, PA: HMP Communications, 2012:243–252.
30.
PaulingL. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease. Science, 1968; 160:265–271.
31.
PaulingL, PaulingL, MoertelC. A proposition: megadoses of vitamin C are valuable in the treatment of cancer. Nutr Rev, 1986; 44:28–29.
32.
Pinchcofsky-DevinGD, KaminskiMVJr. Correlation of pressure sores and nutritional status. J Am Geriatr Soc, 1986; 34:435–440.
33.
ThomasDR. The role of nutrition in prevention and healing of pressure ulcers. Clin Geriatr Med, 1997; 13:497–511.
34.
BerlowitzDR, WilkingSV. Risk factors for pressure sores. A comparison of cross-sectional and cohort-derived data. J Am Geriatr Soc, 1989; 37:1043–1050.
35.
GreenSM, WinterbergH, FranksPJ, et al. Nutritional intake in community patients with pressure ulcers. J Wound Care, 1999; 8:325–330.
36.
DesnevesKJ, TodorovicBE, CassarA, CroweTC. Treatment with supplementary argine, vitamin C and zinc in patients with pressure ulcers: a randomized contolled trial. Clin Nutr, 2005; 24:979–987.
37.
Van AnholtRD, SobotkaL, MeijerEP, et al. Specific nutritional support accelerates pressure ulcer healing and reduces wound care intensity in non-malnourished patients. Nutrition, 2010; 26:867–872.
SurjusheA, VasaniR, SapleDG. Aloe vera: A short review. Indian J Dermatol., 2008; 53:163–166.
40.
FultonJE. The stimulation of postdermabrasion wound healing with stabilised aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol, 1990; 16:460–467.
41.
SchmidtJM, GreenspoonJS. Aloe vera dermal wound gel is associated with a delay in wound healing. Obstet Gynecol, 1991; 1:115–117.
42.
MuranduM, WebberMA, SimmsMH, DealeyC. Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study. J Wound Care, 2011; 20:206–216.
43.
MuranduM, DealeyC. The use of granulated sugar to treat two pressure ulcers. Wounds Int, 2009; 1:1–4.
44.
KnutsonRA, MerbitzLA, CreekmoreAA, SnipesLG. Use of sugar and povidone-iodine to enhance wound healing: five years' experience. South Med J, 1981; 74:1329–1335.
45.
NakaoH, YamazakiM, TsuboiR, OgawaH. Mixture of sugar and povidone-iodine stimulates wound healing by activating keratinocytes and fibroblast functions. Arch Dermatol Res, 2006; 298:175–182.
46.
ShiCM, NakaoH, YamazakiM, TsuboiR, OgawaH. Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice. Arch Dermatol Res, 2007; 299:449–456.
47.
Klouchek-PopovaE, PopovaA, PavlovaN, KrustevaS. Influence of the physiological regeneration and epithelialization using fractions isolated from Calendula officinalis. Acta Physiol Pharmacol Bulg, 1982; 8:63–67.
48.
McQuestionM. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs, 2011; 27:e1–e17.
49.
SzaboE, BujdosoJ. Calendula officinalis in wound treatment. Nover, 1994; 7:20–22.
50.
NetoJ, FracassoJ, Camargo NevesC, et al. Treatment of varicose ulcer and skin lesions with Calendula officinalis L. or Stryphnodendron barbadetiman (Vellozo) Martius. Rev Cienc Farm, 1996; 17:181–186.
51.
DuranV, MaticM, JovanovicM, et al. Results of the clinical examination of an ointment with marigold (Calendula officinalis) extract in the treatment of venous leg ulcers. Int J Tissue React, 2005; 27:101–106.
52.
UptonR. St. John's Wort Monograph. Herbalgram #40. American Herbal Pharmacopoeia. Summer, 1997; 3–38.
53.
MolanPC. Honey as a topical antibacterial agent for treatment of infected wounds. World Wide Wounds. Published 2001 at www.worldwidewounds.com/2001/november/Molan/honey-as-topical-agent.html#ref89 (accessed February1, 2014).
54.
MolanPC. The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World, 1992; 73:5–28.
55.
AllenKL, HutchinsonG, MolanPC. The potential for using honey to treat wounds infected with MRSA and VRE. Melbourne, Australia: First World World Healing Congress, 2000.
56.
AllenKL, MolanPC, ReidGM. A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol, 1991; 43:817–822.
57.
JullAB, RodgersA, WalkerN. Honey as a topical treatment for wounds. Cochrane Database Syst Rev, 2008:CD005083.
58.
JullA, WalkerN, ParagV, MolanP, RodgersA. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg, 2008; 95:175–182.
59.
GethinG, CowmanS. Manuka honey vs. hydrogel-a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs, 2009; 18:466–474.
60.
WeheidaSM, NagubibHH, El-BannaHM, MarzoukS. Comparing the effects of two dressing techniques on healing of low grade pressure ulcers. J Med Res Inst, 1991; 12:259–278.
61.
Yapucu GunesU, EserI. Effectiveness of a honey dressing for healing pressure ulcers. J Wound Ostomy Continence Nurs, 2007; 34:184–190.
62.
ShukrimiA, SulaimanAR, HalimAY, AzrilA. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia, 2008; 63:44–46.
